Lauren Stival Hopfer

Lauren Stival Hopfer has extensive experience in investor relations and corporate communications. Lauren currently holds the position of Senior Vice President at Kendall Investor Relations, LLC since December 2022. Prior to this, they worked as an Investor Relations professional at Sporos Bioventures starting in October 2021. From June 2020 to May 2021, they held the role of Senior Director of Investor Relations at Dicerna Pharmaceuticals, Inc. Before that, they worked at Stern Investor Relations as a Vice President from December 2018 to June 2020 and as a Managing Director from June 2019 to May 2020. From 2016 to 2018, they served as the Senior Director of Investor Relations and Corporate Communications at Avadel Pharmaceuticals plc. Lauren also has experience as a Vice President of Healthcare Investor Relations at ICR from 2014 to 2016. Earlier in their career, they worked as a Market Analyst at Thomson Reuters, held a role in Institutional Sales and Marketing at Gleacher & Company, and served as an Investment Banking Analyst at MD Global Partners.

Lauren Stival Hopfer attended Blair Academy for high school. Lauren later earned a Bachelor of Arts degree from Duke University and also pursued further education at Duke University - The Fuqua School of Business.